The U.S. Food and Drug Administration (FDA) announced on September 16, 2021 that the drug manufacturer Pfizer is voluntarily recalling all lots of Chantix 0.5 mg and 1 mg tablets due to the presence of a nitrosamine, N-nitroso-varenicline, a probable human carcinogen (a substance that could cause cancer). As alternative suppliers have been approved in the United States, Pfizer is undertaking this precautionary measure.

We remind you that effective November 1, 2021, we can no longer accept faxes at the phone numbers listed on the reverse of this notice.

Excellus BlueCross BlueShield (BCBS) has implemented the requirements included in Governor Hochul’s Executive Order #4, issued September 27, 2021 for its fully insured members. In addition, Excellus BCBS has extended these requirements to its Medicare line of business.